Market Overview:
The global point-of-care (POC) testing devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for POC testing devices due to their ease of use and rapid results. In addition, the growing prevalence of chronic diseases is also contributing to the growth of this market. The global POC testing devices market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into troponin test, brain natriuretic peptide test (BNP), and others. The BNP segment is expected to grow at a higher CAGR during the forecast period as it helps in early diagnosis and treatment of heart failure patients.
 Testing Devices Industry Outlook.svg)
Product Definition:
Point-of-care (POC) testing devices are medical devices that are used to test a patient’s blood or other bodily fluids for the presence of various diseases or conditions. These devices can be used in a variety of settings, including hospitals, clinics, and even at home. Their primary benefit is that they provide results quickly and allow healthcare providers to begin treatment immediately if necessary. Additionally, POC testing devices can often be used to diagnose conditions that are not easily detectable with traditional lab tests.
Troponin Test:
The troponin test is used to detect the presence of cardiac markers in patients suspected of having a heart attack. It also helps in differentiating between an acute myocardial infarction and other forms of cardiovascular disease. The rising prevalence rate of cardiovascular diseases across the globe has led to an increase in demand for rapid, accurate, and sensitive POC testing devices that can aid early diagnosis.
Brain Natriuretic Peptide Test:
The brain natriuretic peptide test is used to diagnose acute hydrocephalus and other central nervous system (CNS) disorders. It is also used as a marker for the diagnosis of multiple sclerosis, dementia, stroke, and traumatic injury.
Application Insights:
The others segment includes immunoassays, rapid testing devices for infectious diseases, and point-of-care HIV tests. The immunoassays segment dominated the global market in terms of revenue in 2017 due to its wide application across a variety of settings. Immunoassays are used at clinics as well as hospitals and other healthcare facilities for the detection of various chronic diseases such as cancer, diabetes mellitus, autoimmune disorders & infections.
On the other hand, point-of-care blood glucose tests are expected to grow at a lucrative rate during the forecast period owing to their increasing use by clinicians and patients for monitoring blood glucose levels on an outpatient basis. Furthermore, growing awareness about self-monitoring with regard to glycemic control is anticipated fuel demand over the next few years (see figure below).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and increasing healthcare expenditure in this region. Moreover, rising number of research & development activities by companies is also expected to drive the growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness about early diagnosis of diseases.
Moreover, government initiatives are boosting POC diagnostics market across countries such as China.
Growth Factors:
- Increasing demand for rapid and accurate diagnostic tests: The global Point-of-Care (POC) Testing Devices market is expected to grow at a CAGR of 7.5% during the forecast period. This growth can be attributed to the increasing demand for rapid and accurate diagnostic tests, which helps in reducing the turnaround time for patients.
- Rising prevalence of chronic diseases: The global Point-of-Care (POC) Testing Devices market is also driven by the rising prevalence of chronic diseases such as diabetes, cancer, and heart disease. This has led to an increase in the demand for POC testing devices that offer fast results so that appropriate treatment can be initiated without delay.
- Technological advancements: Another key driver for this market is technological advancements that have led to the development of new and innovative POC testing devices such as portable blood glucose meters, point-of-care immunoassay analyzers, etc., which are helping to improve patient care outcomes while reducing costs simultaneously.
Scope Of The Report
Report Attributes
Report Details
Report Title
Point-of-Care (POC) Testing Devices Market Research Report
By Type
Troponin Test, Brain Natriuretic Peptide Test, Others
By Application
Clinics, Hospitals, Laboratories, Others
By Companies
Roche Diagnostics, Abaxis, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, Siemens HealthCare Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Point-of-Care (POC) Testing Devices Market Report Segments:
The global Point-of-Care (POC) Testing Devices market is segmented on the basis of:
Types
Troponin Test, Brain Natriuretic Peptide Test, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abaxis
- Abbott
- Beckman Coulter
- Beckton and Dickinson
- Bayer Diabetes Care
- Hemocue AB
- International Technidyne Corporation
- LifeScan Inc
- Nipro Diagnostics
- Orasure Technologies
- PointCare Technologies
- Siemens HealthCare Diagnostics
 Testing Devices Market Overview.svg)
Highlights of The Point-of-Care (POC) Testing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Troponin Test
- Brain Natriuretic Peptide Test
- Others
- By Application:
- Clinics
- Hospitals
- Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point-of-Care (POC) Testing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Devices Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point-of-care (POC) testing devices are medical devices that can be used to test a person's blood, urine, or other bodily fluids at the point of care. They are often small and portable, making them easy to use in hospitals and clinics.
Some of the key players operating in the point-of-care (poc) testing devices market are Roche Diagnostics, Abaxis, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, Siemens HealthCare Diagnostics.
The point-of-care (poc) testing devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point-of-Care (POC) Testing Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Point-of-Care (POC) Testing Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Point-of-Care (POC) Testing Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Point-of-Care (POC) Testing Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Point-of-Care (POC) Testing Devices Market Size & Forecast, 2018-2028
4.5.1 Point-of-Care (POC) Testing Devices Market Size and Y-o-Y Growth
4.5.2 Point-of-Care (POC) Testing Devices Market Absolute $ Opportunity
Chapter 5 Global Point-of-Care (POC) Testing Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Point-of-Care (POC) Testing Devices Market Size Forecast by Type
5.2.1 Troponin Test
5.2.2 Brain Natriuretic Peptide Test
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Point-of-Care (POC) Testing Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Point-of-Care (POC) Testing Devices Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Laboratories
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Point-of-Care (POC) Testing Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Point-of-Care (POC) Testing Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Point-of-Care (POC) Testing Devices Analysis and Forecast
9.1 Introduction
9.2 North America Point-of-Care (POC) Testing Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Point-of-Care (POC) Testing Devices Market Size Forecast by Type
9.6.1 Troponin Test
9.6.2 Brain Natriuretic Peptide Test
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Point-of-Care (POC) Testing Devices Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Laboratories
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Point-of-Care (POC) Testing Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Point-of-Care (POC) Testing Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Point-of-Care (POC) Testing Devices Market Size Forecast by Type
10.6.1 Troponin Test
10.6.2 Brain Natriuretic Peptide Test
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Point-of-Care (POC) Testing Devices Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Laboratories
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Point-of-Care (POC) Testing Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Point-of-Care (POC) Testing Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Point-of-Care (POC) Testing Devices Market Size Forecast by Type
11.6.1 Troponin Test
11.6.2 Brain Natriuretic Peptide Test
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Point-of-Care (POC) Testing Devices Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Laboratories
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Point-of-Care (POC) Testing Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Point-of-Care (POC) Testing Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Point-of-Care (POC) Testing Devices Market Size Forecast by Type
12.6.1 Troponin Test
12.6.2 Brain Natriuretic Peptide Test
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Point-of-Care (POC) Testing Devices Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Laboratories
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Point-of-Care (POC) Testing Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Point-of-Care (POC) Testing Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Point-of-Care (POC) Testing Devices Market Size Forecast by Type
13.6.1 Troponin Test
13.6.2 Brain Natriuretic Peptide Test
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Point-of-Care (POC) Testing Devices Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Laboratories
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Point-of-Care (POC) Testing Devices Market: Competitive Dashboard
14.2 Global Point-of-Care (POC) Testing Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Abaxis
14.3.3 Abbott
14.3.4 Beckman Coulter
14.3.5 Beckton and Dickinson
14.3.6 Bayer Diabetes Care
14.3.7 Hemocue AB
14.3.8 International Technidyne Corporation
14.3.9 LifeScan Inc
14.3.10 Nipro Diagnostics
14.3.11 Orasure Technologies
14.3.12 PointCare Technologies
14.3.13 Siemens HealthCare Diagnostics
